Marina Romero-Ramos, PhD, graduated summa cum laude from the University of Seville, Spain, with her PhD in 2000. She studied the role of antioxidants in the dopaminergic system in the Department of Biochemistry and Molecular Biology.
She later moved to the USA to work under the supervision of Marie-Francoise Chesselet, MD, PhD, at the University of California, Los Angeles School of Medicine. There, her post-doctoral studies focused on the use of non-neural stem cells for neural replacement.
In 2002, she became a Marie Curie Fellow and for the following three years developed a pre-clinical model of Parkinson's disease (PD) in collaboration with Deniz Kirik, MD, PhD, and Anders Bjorklund, MD, PhD, at Lund University, Sweden.
She is currently an associate professor at the Health Faculty, Aarhus University, Denmark, where she has been leading the Central Nervous System Disease Modeling group since 2006.
Dr. Romero-Ramos's laboratory is affiliated with the EMBL Node on Translational Neuroscience, the Danish Research Institute of Translational Neuroscience (DANDRITE). The focus of her research is pre-clinical modeling of factors involved in neurodegeneration in Parkinson's disease, such as protein mishandling and inflammation.
Associated Grants
-
Study of the Role of Phosphorylation at Ser 129 in Alpha-synuclein Induced Dopaminergic Neurodegeneration in a Rodent Model of Parkinson's Disease
2006